Ilika plc with ticker (LON:IKA) now has a potential upside of 159.5% according to Berenberg Bank.
Berenberg Bank set a target price of 120 GBX for the company, which when compared to the Ilika plc share price of 46 GBX at opening today (12/12/2023) indicates a potential upside of 159.5%. Trading has ranged between 23 (52 week low) and 72 (52 week high) with an average of 201,730 shares exchanging hands daily. The market capitalisation at the time of writing is £73,872,891.
Ilika plc is a United Kingdom-based company. The Company is engaged in developing and commercializing its cutting-edge solid-state batteries. The Company develops and commercializes its thin-film Stereax miniature solid-state batteries for powering implantable medical devices and industrial wireless sensors (IIoT) in specialist environments, as well as progressing the development of its large-format Goliath cells for electric vehicles (EV) and cordless appliances. It has a secured lease of approximately 1,600 square meters property for Stereax manufacturing scale-up and installed over 340 square meters clean room facility. The Company is enabling solutions for applications, such as industrial Internet of things (IoT), MedTech, electric vehicles (EV) and consumer electronics. The Company has its operations in the United States of America, China and Israel.
Ilika plc 159.5% potential upside indicated by Berenberg Bank
- Written by: Charlotte Edwards
Find more news, interviews, share price & company profile here for:
Latest Company News
Ilika has started delivering its 10Ah Goliath solid state battery prototypes, offering five times the capacity of earlier versions and manufactured on its new automated pilot line.
Ilika is translating niche micro-battery expertise into a larger bet on scalable solid-state solutions for EVs and energy storage.
Ilika is stepping directly into the medical-device market with its solid-state microbattery platform now featured at NANS 2026.
Ilika’s solid-state cells allowed a full battery pack redesign, cutting 100 kg, lowering cost, and extending range, without compromising safety.
Ilika's Graeme Purdy shares updates on the company’s advancements in solid-state battery technology, including Stereax manufacturing milestones, the upcoming release of Goliath P1.5 prototypes, and expanding customer interest across medical and industrial sectors.
Graeme Purdy, CEO of Ilika plc, outlines how solid-state Stereax batteries are entering production at Cirtec—with customer-ready units already on test. Applications span implanted sensors to orthodontics, and next-gen Goliath cells are primed for delivery by year-end.
